Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and ...

EYLEA HD is anticipated to gain traction with the launch of a prefilled syringe in mid-2025 and label expansions for macular edema and extended dosing intervals. Management believes these developments ...

Let's help them breathe easy again with natural solutions like PhytoRelief-Plus immunity lozenges, exercise, and a healthy ...

A practice in Texas, that employs concierge-level of care personalized for the patient and offers a holistic medicine approach. This practice emphasizes prevention, reduction of hospital admissions ...

Regeneron reported Q4 2024 earnings today and declared its first-ever dividend of $0.88 per quarter. Click here to know what ...

Finding it hard to breathe when you lay down is medically called orthopnea. Find a list of potential causes to help narrow down your overall risk here.

Summary The Chart of the Day belongs to biotechnology company Verona Pharma (VRNA) . I found the stock by using Barchart's ...

Dr. Wimms brings two decades of sleep medicine industry and research expertise to her advisory role at Incannex. Dr. Wimms holds a Doctor of Philosophy (Ph.D.) in Medicine, and Master of Medicine ...

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

The pilot will provide 1,000 tests over the period of 18 months and will be made available across three sites in South Ayrshire. It will initially start in Girvan Community Hospital with two ...

Sales of Eylea, which the company co-developed with Bayer (DE:BAYA), rose 2% to $1.495 billion. Sales of the higher-dose, longer-lasting formulation Eylea HD rose 148% to $305 million in the U.S., ...

Indian researchers tested the supplement in an experiment on 80 participants between the age of 18 and 55 half of who were given a 300mg dose and other half a placebo.